<!DOCTYPE html>

<html lang="en">

<head>

  <meta charset="UTF-8" />

  <meta http-equiv="X-UA-Compatible" content="IE=edge" />

  <meta name="viewport" content="width=device-width, initial-scale=1.0" />

  <title>Novartis COSENTYX® for healthcare professionals</title>



  <link rel="stylesheet" href="assets/css/fontawesome.min.css" />

  <link rel="stylesheet" href="assets/css/bootstrap.min.css" />

  <link rel="stylesheet" href="assets/css/style.css" />

  <link rel="stylesheet" href="assets/css/responsive.css" />

  <!-- Google Tag Manager -->
  <script>(function (w, d, s, l, i) {
      w[l] = w[l] || []; w[l].push({
        'gtm.start':
          new Date().getTime(), event: 'gtm.js'
      }); var f = d.getElementsByTagName(s)[0],
        j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
          'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
    })(window, document, 'script', 'dataLayer', 'GTM-WR4CQQS');</script>
  <!-- End Google Tag Manager -->

</head>

<body>
  <!-- Google Tag Manager (noscript) -->
  <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-WR4CQQS" height="0" width="0"
      style="display:none;visibility:hidden"></iframe></noscript>
  <!-- End Google Tag Manager (noscript) -->

  <!-- start header section -->

  <header>

    <div class="mobile-menu">

      <div>

        <i class="fas fa-times"></i>

        <nav>


          <li><a href="home.html">Home</a></li>

          <li><a href="safty-information.html">Important safety information</a></li>

          <li class="language-switcher"><a href="#">Français</a></li>

          </ul>

        </nav>

      </div>

    </div>

    <div class="container">

      <a href="home.html" class="logo">

        <img src="assets/images/logo.svg" alt="Logo" />

      </a>

      <img src="assets/images/skew-bars.png" alt="Bars" />

      <div class="toggle-bar ms-auto">

        <img class="d-lg-none" src="assets/images/menu-bars.png" alt="" />

      </div>

      <nav>

        <ul>

          <li><a href="home.html">Home</a></li>

          <li><a href="safty-information.html">Important safety information</a></li>

          <li class="language-switcher"><a href="#">Français</a></li>

        </ul>

      </nav>

    </div>

  </header>

  <!-- end header section -->



  <section id="safty-information" class="content-bg">

    <div class="container">

      <h2 class="d-none d-md-block">Important Safety Information</h2>

      <h2 class="d-md-none">Helping your patients

        face their day</h2>

      <div class="si-item">

        <h3>Indication and clinical use:</h3>

        <p>COSENTYX<sup>®</sup> (secukinumab) is indicated for the treatment of:</p>

        <ul>

          <li>

            Moderate to severe plaque psoriasis in adult patients who are

            candidates for systemic therapy or phototherapy

          </li>

          <li>

            Severe plaque psoriasis in pediatric patients 12 to less than 18

            years of age who are candidates for systemic therapy or

            phototherapy and have a body weight ≥50 kg

          </li>

          <li>

            Adult patients with active psoriatic arthritis when the response

            to previous disease-modifying anti-rheumatic drug (DMARD) therapy

            has been inadequate. COSENTYX<sup>®</sup> can be used alone or in combination

            with methotrexate

          </li>

          <li>

            Adult patients with active ankylosing spondylitis who have

            responded inadequately to conventional therapy

          </li>

          <li>

            Active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by
            elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have
            responded inadequately, or are intolerant to nonsteroidal anti-inflammatory drugs (NSAIDs).
          </li>

        </ul>

        <p>

          Geriatric patients ≥65 years of age: although limited in patient

          numbers, no differences in safety or efficacy were observed between

          older and younger patients.

        </p>

        <p>

          Pediatrics &lt;18 years of age: safety and effectiveness in

          pediatric patients with severe plaque psoriasis below the age of 12

          years have not been established. Safety and effectiveness in

          pediatric patients with the principal diagnosis of psoriatic

          arthritis or ankylosing spondylitis below the age of 18 years have

          not been established.

        </p>

      </div>

      <div class="si-item">

        <h3>Contraindications:</h3>

        <ul>

          <li>

            Severe hypersensitivity to the active substance or any of its

            components

          </li>

        </ul>

      </div>

      <div class="si-item">

        <h3>Relevant warnings and precautions:</h3>

        <ul>

          <li>

            Infections: could potentially increase risk of infections; caution

            in patients with a chronic infection or history of recurrent

            infections; patients should be evaluated for tuberculosis prior to

            initiation of treatment with COSENTYX<sup>®</sup>

          </li>

          <li>Caution in patients with active inflammatory bowel disease</li>

          <li>

            Caution in latex-sensitive patients: natural rubber latex

            derivatives in the removable cap of the prefilled

            syringe/COSENTYX<sup>®</sup> SensoReady<sup>®</sup> pen

          </li>

          <li>

            Consider completion of all age-appropriate immunizations according to current guidelines prior to treatment;
            should not be used with live

            vaccinations; can be used with those that are inactivated or non-live

          </li>

          <li>

            Hypersensitivity reactions: rare cases of anaphylaxis and cases of

            urticaria occurred in COSENTYX<sup>®</sup>-treated patients in clinical

            trials

          </li>

          <li>

            Pregnancy: should only be used if the potential benefit justifies

            the potential risk to the fetus

          </li>

          <li>Nursing women: caution should be exercised</li>

        </ul>

      </div>

      <div class="si-item">

        <h3>For more information:</h3>

        <p>

          Consult the Product Monograph at

          <a target="_blank" href="http://www.novartis.ca/CosentyxMonograph">www.novartis.ca/CosentyxMonograph</a>

          for important information relating to adverse reactions, drug

          interactions and dosing information which has not been discussed in

          this piece. The Product Monograph is also available by calling

          1-800-363-8883.

        </p>

      </div>

    </div>

  </section>



  <!-- start footer section -->

  <footer>

    <div class="footer-main">

      <div class="container">

          <div class="row align-items-end">

              <div class="col-xl-6">

                  <div class="fm-left d-flex align-items-center">

                      <img src="assets/images/footer-left-logo.svg" alt="Footer Logo" />

                      <div class="footer-content">

                          <p>

                              COSENTYX, SensoReady and XPOSE are registered trademarks.

                              <br />

                              Product Monograph available on request. <br />

                              183804E <br />

                              © Novartis Pharmaceuticals Canada Inc. February 2023

                          </p>

                      </div>

                  </div>

              </div>

              <div class="col-xl-2">

                  <ul class="d-flex privacy-terms">

                      <li>

                          <a href="privacy-policy.html">Privacy policy</a> |

                          <a href="terms-of-use.html">Terms of use</a>

                      </li>

                  </ul>

              </div>

              <div class="col-xl-4">

                  <div class="fm-right d-flex align-items-center justify-content-end">

                      <img src="assets/images/footer-middle-logo.svg" alt="" />

                      <img src="assets/images/footer-right-logo.svg" alt="" />

                  </div>

              </div>

          </div>

      </div>

  </div>

  </footer>

  <!-- end footer section -->

  <script src="assets/js/jquery-3.6.0.min.js"></script>
  <script src="assets/js/index.js"></script>

</body>

</html>